Tris Pharma Inc

NJ · United States · Reporting entity ID 100000011232

Total reported 2019–2025

$25.8M

#268 of 2,960 reporting companies — 0% of all reported industry payments

$5.48M in general payments across 129,049 records, plus $20.3M in research funding across 252 records.

How it breaks down

General payments $5,483,171

Research funding $20,322,168

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.